Literature DB >> 19949066

Marginal zone precursor B cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity.

John H Wang1, Jun Li, Qi Wu, PingAr Yang, Rahul D Pawar, Shutao Xie, Laura Timares, Chander Raman, David D Chaplin, Lu Lu, John D Mountz, Hui-Chen Hsu.   

Abstract

The pathogenic connection of type I IFN and its role in regulating the migration response of Ag delivery by B cells into lymphoid follicles in an autoimmune condition has not been well-identified. Here, we show that there was a significantly larger population of marginal zone precursor (MZ-P) B cells, defined as being IgM(hi)CD1d(hi)CD21(hi)CD23(hi) in the spleens of autoimmune BXD2 mice compared with B6 mice. MZ-P B cells were highly proliferative compared with marginal zone (MZ) and follicular (FO) B cells. The intrafollicular accumulation of MZ-P B cells in proximity to germinal centers (GCs) in BXD2 mice facilitated rapid Ag delivery to the GC area, whereas Ag-carrying MZ B cells, residing predominantly in the periphery, had a lower ability to carry Ag into the GCs. IFN-alpha, generated by plasmacytoid dendritic cells, induced the expression of CD69 and suppressed the sphingosine-1-phosphate-induced chemotactic response, promoting FO-oriented Ag transport by MZ-P B cells. Knockout of type I IFN receptor in BXD2 (BXD2-Ifnalphar(-/-)) mice substantially diffused the intrafollicular MZ-P B cell conglomeration and shifted their location to the FO-MZ border near the marginal sinus, making Ag delivery to the FO interior less efficient. The development of spontaneous GCs was decreased in BXD2-Ifnalphar(-/-) mice. Together, our results suggest that the MZ-P B cells are major Ag-delivery B cells and that the FO entry of these B cells is highly regulated by type I IFN-producing plasmacytoid dendritic cells in the marginal sinus in the spleens of autoimmune BXD2 mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19949066      PMCID: PMC2830207          DOI: 10.4049/jimmunol.0900870

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

Authors:  A Le Bon; G Schiavoni; G D'Agostino; I Gresser; F Belardelli; D F Tough
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

Review 2.  Models for peripheral B cell development and homeostasis.

Authors:  Bhaskar Srivastava; R Coleman Lindsley; Neda Nikbakht; David Allman
Journal:  Semin Immunol       Date:  2005-06       Impact factor: 11.130

Review 3.  Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20).

Authors:  Robert Eisenberg
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2006-12       Impact factor: 2.895

Review 4.  Type-I interferons and systemic lupus erythematosus.

Authors:  Sophie Koutouzov; Alexis Mathian; Ali Dalloul
Journal:  Autoimmun Rev       Date:  2006-06-27       Impact factor: 9.754

5.  Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies.

Authors:  Hui-Chen Hsu; Yalei Wu; Pingar Yang; Qi Wu; Godwin Job; Jian Chen; John Wang; Mary Ann V Accavitti-Loper; William E Grizzle; Robert H Carter; John D Mountz
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

6.  Follicular exclusion of autoreactive B cells requires FcgammaRIIb.

Authors:  Elahna Paul; Annette Nelde; Admar Verschoor; Michael C Carroll
Journal:  Int Immunol       Date:  2007-02-16       Impact factor: 4.823

7.  Production of a novel class of polyreactive pathogenic autoantibodies in BXD2 mice causes glomerulonephritis and arthritis.

Authors:  Hui-Chen Hsu; Tong Zhou; Helen Kim; Stephen Barnes; PingAr Yang; Qi Wu; Juling Zhou; Bruce A Freeman; Ming Luo; John D Mountz
Journal:  Arthritis Rheum       Date:  2006-01

8.  CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.

Authors:  Lawrence R Shiow; David B Rosen; Nadezda Brdicková; Ying Xu; Jinping An; Lewis L Lanier; Jason G Cyster; Mehrdad Matloubian
Journal:  Nature       Date:  2006-03-08       Impact factor: 49.962

9.  Characterization of marginal zone B cell precursors.

Authors:  Bhaskar Srivastava; William J Quinn; Kristin Hazard; Jan Erikson; David Allman
Journal:  J Exp Med       Date:  2005-10-31       Impact factor: 14.307

10.  B cells and professional APCs recruit regulatory T cells via CCL4.

Authors:  R S Bystry; V Aluvihare; K A Welch; M Kallikourdis; A G Betz
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

View more
  25 in total

Review 1.  Cytokine regulation of B-cell migratory behavior favors formation of germinal centers in autoimmune disease.

Authors:  John D Mountz; John H Wang; Shutao Xie; Hui-Chen Hsu
Journal:  Discov Med       Date:  2011-01       Impact factor: 2.970

2.  IL-23 Promotes a Coordinated B Cell Germinal Center Program for Class-Switch Recombination to IgG2b in BXD2 Mice.

Authors:  Huixian Hong; Min Gao; Qi Wu; PingAr Yang; Shanrun Liu; Hao Li; Peter D Burrows; Daniel Cua; Jake Y Chen; Hui-Chen Hsu; John D Mountz
Journal:  J Immunol       Date:  2020-06-17       Impact factor: 5.422

3.  CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent.

Authors:  Keith M Woods; Michael R Pope; Sara M Hoffman; Sherry D Fleming
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

4.  p53 negatively regulates RGS13 protein expression in immune cells.

Authors:  Shoko Iwaki; Yunbiao Lu; Zhihui Xie; Kirk M Druey
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

5.  General Approach for Tetramer-Based Identification of Autoantigen-Reactive B Cells: Characterization of La- and snRNP-Reactive B Cells in Autoimmune BXD2 Mice.

Authors:  Jennie A Hamilton; Jun Li; Qi Wu; PingAr Yang; Bao Luo; Hao Li; John E Bradley; Justin J Taylor; Troy D Randall; John D Mountz; Hui-Chen Hsu
Journal:  J Immunol       Date:  2015-04-17       Impact factor: 5.422

6.  Cutting Edge: defective follicular exclusion of apoptotic antigens due to marginal zone macrophage defects in autoimmune BXD2 mice.

Authors:  Hao Li; Qi Wu; Jun Li; PingAr Yang; Zilu Zhu; Bao Luo; Hui-Chen Hsu; John D Mountz
Journal:  J Immunol       Date:  2013-03-29       Impact factor: 5.422

Review 7.  Role of type I interferons in the activation of autoreactive B cells.

Authors:  Kerstin Kiefer; Michael A Oropallo; Michael P Cancro; Ann Marshak-Rothstein
Journal:  Immunol Cell Biol       Date:  2012-03-20       Impact factor: 5.126

Review 8.  Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.

Authors:  Vaishali R Moulton; Abel Suarez-Fueyo; Esra Meidan; Hao Li; Masayuki Mizui; George C Tsokos
Journal:  Trends Mol Med       Date:  2017-06-13       Impact factor: 11.951

9.  Cutting Edge: Endogenous IFN-β Regulates Survival and Development of Transitional B Cells.

Authors:  Jennie A Hamilton; Qi Wu; PingAr Yang; Bao Luo; Shanrun Liu; Huixian Hong; Jun Li; Mark R Walter; Eleanor N Fish; Hui-Chen Hsu; John D Mountz
Journal:  J Immunol       Date:  2017-09-13       Impact factor: 5.422

Review 10.  Dysregulation of T Follicular Helper Cells in Lupus.

Authors:  John D Mountz; Hui-Chen Hsu; Andre Ballesteros-Tato
Journal:  J Immunol       Date:  2019-03-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.